Not Yet RecruitingEUCTR 2022-001244-15
This study isn't recruiting yet.
This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.
Multiple locations, including BrestSchizophreniaHistorical research record
- Countries
- France
- Sponsor
- GHU Paris Psychiatrie et Neurosciences
RecruitingNCT07226895
Official study titleA Study to Explore Changes in Cognitive, Clinical, Biological and Digital Measures Following 8 Weeks of Twice-daily Dosing of MT1988 and to Evaluate Safety & Tolerability of MT1988, in Participants at Clinical High Risk (CHR) for Psychosis
Multiple locations, including IrvineSchizophreniaMedication studyAges 17–30
- Countries
- United States
- Sponsor
- Monument Therapeutics Limited
RecruitingNCT06692530
About this title
Asylumseekers Experiencing Paranoid Delusions: A Virtual Reality Study
Read the official source — NCT06692530Official study titleParanoid Behaviour & Threat Evaluation in Asylumseekers Diagnosed With a Psychotic Disorder and Experiencing Paranoid Delusions: A Phenomenological Qualitative Virtual Reality Study
In BalkbrugSchizophreniaObservational studyAges 18+
- Countries
- Netherlands
- Sponsor
- University Medical Center Groningen
RecruitingNCT07417904
Official study titleYoung Adults and Violent Behavior During Early Psychosis (Aim 3)
In Washington D.C.SchizophreniaBehavioural studyAges 16–30
- Countries
- United States
- Sponsor
- Howard University
RecruitingNCT07483294
Official study titleCerebellar-cortical Circuitry and Prediction of Treatment Response in Early Psychosis
In Glen OaksSchizophreniaMedication studyAges 15–40
- Countries
- United States
- Sponsor
- Northwell Health
RecruitingNCT07196423
About this title
Early Psychosis: Investigating Cognition
Read the official source — NCT07196423Official study titleGlutamate Changes as a New Neurocognitive Marker in Psychosis
In NottinghamSchizophreniaStudy assessmentsAges 18–55
- Countries
- United Kingdom
- Sponsor
- University of Nottingham
RecruitingNCT07459244
Official study titleElectrocardiogram Findings in Methamphetamine Use Disorder and Methamphetamine-Induced Psychotic Disorder: A Prospective Observational Cohort Study
In ElâzığSchizophreniaObservational studyAges 18–65
- Countries
- Türkiye
- Sponsor
- Elazığ Mental Health and Diseases Hospital
RecruitingNCT05282277
About this title
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
Read the official source — NCT05282277Official study titleExamining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis
In Chapel HillSchizophrenia, DepressionMedication studyAges 45–55
- Countries
- United States
- Sponsor
- University of North Carolina, Chapel Hill
RecruitingNCT07225179
Official study titleBolster-NC: A Pilot Study of the Bolster mHealth Intervention Within Early Psychosis Program Outreach in North Carolina
In Chapel HillSchizophreniaBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- University of North Carolina, Chapel Hill
RecruitingNCT07360665
Official study titlePEP - Physical Exercise for Psychosis: A Study Protocol
In Vila RealSchizophreniaInterventional studyAges 18+
- Countries
- Portugal
- Sponsor
- University of Trás-os-Montes and Alto Douro
RecruitingNCT06978894
About this title
Predicting Psychotic Relapse Using Speech-Based Early Detection
Read the official source — NCT06978894Official study titlePredicting Psychotic Relapse Using Speech-Based Early Detection
Multiple locations, including LondonSchizophreniaObservational studyAges 16+
- Countries
- Canada
- Sponsor
- Douglas Mental Health University Institute
RecruitingNCT07041463
About this title
Psychoeducation Program for Family Caregivers Coordinated by an APRN
Read the official source — NCT07041463Official study titleImpact of a New Psychoeducation Program Coordinated by an Advanced Practce Nurse on the Burden of Family Caregivers of Patients With a First Pyschotic Episode.
In BronSchizophreniaInterventional studyAges 18+
- Countries
- France
- Sponsor
- Hôpital le Vinatier